Mediators of Chronic Obstructive Pulmonary Disease
By P. Barnes. Pharmacological Reviews, 2004
730 citations recorded by the source corpus.
Subfields: Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/d5d9c90594a2564e0af2d6330c80d00598d93342
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Immunology of asthma and chronic obstructive pulmonary disease (2008, background): “Inflammatory cells and mediators There are many differences between mild asthma and COPD in the type of inflammation that occurs in the lungs, with a different range of inflammatory cells and mediators being implicate”
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases (2017, neutral): “COPD is a leading cause of morbidity and mortality in developed countries and is characterized by progressive and irreversible airflow obstruction caused by fibrosis and narrowing of small airways, and destruction of alveolar attachments (emphysema), which are heavily mediated by neutrophils and lym”
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005 (2006, background): “The pattern of inflammation clearly differs between these diseases, with the involvement of many different cells and mediators (Barnes et al., 1998; Barnes, 2004b), but all are characterised by increased expression of multiple inflammatory proteins, some of which are common to all inflammatory…”